Walter V. Klemp, Chief Executive Officer at Moleculin Biotech, Inc. (MBRX), sold 100,000 shares at $1.70 ($170K) on 2017-08-16, disclosed to the SEC on 2017-08-18.
Open-market sale of $170k MBRX by Chief Executive Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| MBRX | BUY | 2022-11-28 | $58K | — | Filing → |
| MBRX | BUY | 2022-11-23 | $26K | — | Filing → |
| MBRX | BUY | 2022-11-18 | $191K | — | Filing → |